| MicroRNA‐222 and MicroRNA‐146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer JC Lee, JT Zhao, RJ Clifton‐Bligh, A Gill, JS Gundara, JC Ip, AR Glover, ... Cancer 119 (24), 4358-4365, 2013 | 206 | 2013 |
| International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma B Xu, TL Fuchs, S Ahmadi, M Alghamdi, B Alzumaili, MA Bani, E Baudin, ... Journal of Clinical Oncology 40 (1), 96-104, 2022 | 105 | 2022 |
| microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma AR Glover, JT Zhao, AJ Gill, J Weiss, N Mugridge, E Kim, AL Feeney, ... Oncotarget, 2015 | 98 | 2015 |
| A proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis TL Fuchs, AJ Nassour, A Glover, MS Sywak, SB Sidhu, LW Delbridge, ... The American journal of surgical pathology 44 (10), 1419-1428, 2020 | 71 | 2020 |
| Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence AR Glover, JT Zhao, JC Ip, JC Lee, BG Robinson, AJ Gill, PSH Soon, ... Endocrine-Related Cancer 22 (1), 99-109, 2015 | 66 | 2015 |
| Molecular markers guiding thyroid cancer management C Nylén, R Mechera, I Maréchal-Ross, V Tsang, A Chou, AJ Gill, ... Cancers 12 (8), 2164, 2020 | 63 | 2020 |
| Current management options for recurrent adrenocortical carcinoma AR Glover, JCY Ip, JT Zhao, PSH Soon, BG Robinson, SB Sidhu OncoTargets and Therapy 6, 635-643, 2013 | 62 | 2013 |
| Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance JF Lin, PKC Jonker, M Cunich, SB Sidhu, LW Delbridge, AR Glover, ... Surgery 167 (1), 110-116, 2020 | 60 | 2020 |
| The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma AR Glover, JS Gundara, O Norlén, JC Lee, SB Sidhu Gland Surgery 2 (4), 196-205, 2013 | 54* | 2013 |
| MicroRNA Expression Profiles in the Management of Papillary Thyroid Cancer JC Lee, JS Gundara, A Glover, J Serpell, SB Sidhu The Oncologist 19 (11), 1141-1147, 2014 | 52 | 2014 |
| Thyroid cancer in the age of COVID-19 VHM Tsang, M Gild, A Glover, R Clifton-Bligh, BG Robinson Endocrine-Related Cancer 27 (11), R407-R416, 2020 | 47 | 2020 |
| Use of the nerve integrity monitor during thyroid surgery aids identification of the external branch of the superior laryngeal nerve AR Glover, O Norlén, JS Gundara, M Morris, SB Sidhu Annals of Surgical Oncology 22 (6), 1768-1773, 2015 | 45 | 2015 |
| Risk of needing completion thyroidectomy for low‐risk papillary thyroid cancers treated by lobectomy SBS AN DiMarco, MS Wong, J Jayasekara, D Cole‐Clark, A Aniss, AR Glover, LW ... BJS Open, 2019 | 43 | 2019 |
| Improving outcomes in adrenocortical cancer: An Australian perspective JCY Ip, TCY Pang, AR Glover, P Soon, S Clarke, A Richardson, ... Annals of Surgical Oncology 22 (7), 2309-16, 2015 | 30 | 2015 |
| Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancer J Jayasekara, P Jonker, JF Lin, AF Engelsman, MS Wong, S Kruijff, ... Surgery 167 (1), 40-45, 2020 | 28 | 2020 |
| Immunohistochemical Validation of Overexpressed Genes Identified by Global Expression Microarrays in Adrenocortical Carcinoma Reveals Potential Predictive and Prognostic Biomarkers JCY Ip, TCY Pang, AR Glover, P Soon, JT Zhao, S Clarke, BG Robinson, ... The Oncologist 20 (3), 47-56, 2015 | 27 | 2015 |
| Incidence and risk factors for occult level 3 lymph node metastases in papillary thyroid cancer S Fraser, N Zaidi, O Norlén, A Glover, S Kruijff, M Sywak, L Delbridge, ... Annals of surgical oncology 23, 3587-3592, 2016 | 26 | 2016 |
| Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer C Nylén, FB Eriksson, A Yang, A Aniss, J Turchini, D Learoyd, ... The American Journal of Surgery 221 (5), 886-892, 2021 | 25 | 2021 |
| Factors that inform individual decision making between active surveillance, hemithyroidectomy and total thyroidectomy for low-risk thyroid cancer: A scoping review J Wei, M Thwin, B Nickel, A Glover Thyroid 32 (7), 807-818, 2022 | 24 | 2022 |
| microRNA‐431 as a chemosensitizer and potentiator of drug activity in adrenocortical carcinoma GTY Kwok, JT Zhao, AR Glover, AJ Gill, R Clifton‐Bligh, BG Robinson, ... The Oncologist 24 (6), e241-e250, 2019 | 23 | 2019 |
